Presentation is loading. Please wait.

Presentation is loading. Please wait.

Open Public Hearing 1.Congresswoman Donna M. Christensen, M.D. Chair, Congressional Black Caucus [CBC] 1.Congresswoman Donna M. Christensen, M.D. Chair,

Similar presentations


Presentation on theme: "Open Public Hearing 1.Congresswoman Donna M. Christensen, M.D. Chair, Congressional Black Caucus [CBC] 1.Congresswoman Donna M. Christensen, M.D. Chair,"— Presentation transcript:

1 Open Public Hearing 1.Congresswoman Donna M. Christensen, M.D. Chair, Congressional Black Caucus [CBC] 1.Congresswoman Donna M. Christensen, M.D. Chair, Congressional Black Caucus [CBC] Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

2 Open Public Hearing 2.Gary A. Puckrein, Ph.D. National Minority Health Month Foundation 2.Gary A. Puckrein, Ph.D. National Minority Health Month Foundation Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

3 Open Public Hearing 3. B. Waine Kong, J.D., Ph.D. CEO – American Association of Black Cardiologists [ABC] 3. B. Waine Kong, J.D., Ph.D. CEO – American Association of Black Cardiologists [ABC] Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

4 Open Public Hearing 4.Debra Lee Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

5 Open Public Hearing 5. Shomarka Omar Y. Keita, M.D., D.Phil. Medical Officer - Department of Human Services, District of Columbia Research Associate - Anthropology Department, Smithsonian Institution 5. Shomarka Omar Y. Keita, M.D., D.Phil. Medical Officer - Department of Human Services, District of Columbia Research Associate - Anthropology Department, Smithsonian Institution Cardiovascular and Renal Drugs Advisory Committee June 16, 2005 ****

6 Open Public Hearing 6. Jonathan Kahn, J.D., Ph.D. Assistant Professor Hamline University School of Law 6. Jonathan Kahn, J.D., Ph.D. Assistant Professor Hamline University School of Law Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

7 Open Public Hearing 7. Charles L. Curry, M.D., FACC, FACP President - International Society on Hypertension in Blacks 7. Charles L. Curry, M.D., FACC, FACP President - International Society on Hypertension in Blacks Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

8 Open Public Hearing 8. Basil Halliday, M.Sc. President & CEO - BDH Clinical Research Services 8. Basil Halliday, M.Sc. President & CEO - BDH Clinical Research Services Cardiovascular and Renal Drugs Advisory Committee June 16, 2005 ****

9 Open Public Hearing 9.Charles N. Rotimi, Ph.D. National Human Genome Center Howard University 9.Charles N. Rotimi, Ph.D. National Human Genome Center Howard University Cardiovascular and Renal Drugs Advisory Committee June 16, 2005 ****

10 Open Public Hearing 10. Charmaine Royal, Ph.D. National Human Genome Center Howard University 10. Charmaine Royal, Ph.D. National Human Genome Center Howard University Cardiovascular and Renal Drugs Advisory Committee June 16, 2005 ****

11 Open Public Hearing 11. Olivia Carter-Pokras, Ph.D. Associate Professor – University of Maryland, School of Medicine, Dept. of Epidemiology 11. Olivia Carter-Pokras, Ph.D. Associate Professor – University of Maryland, School of Medicine, Dept. of Epidemiology Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

12 Open Public Hearing 12. Lucille C. Norville Perez, MD National Health Director - National Association for the Advancement of Colored People 12. Lucille C. Norville Perez, MD National Health Director - National Association for the Advancement of Colored People Cardiovascular and Renal Drugs Advisory Committee June 16, 2005

13 Open Public Hearing 13. Dianna Wells Cardiovascular and Renal Drugs Advisory Committee June 16, 2005


Download ppt "Open Public Hearing 1.Congresswoman Donna M. Christensen, M.D. Chair, Congressional Black Caucus [CBC] 1.Congresswoman Donna M. Christensen, M.D. Chair,"

Similar presentations


Ads by Google